Market Research Logo

Tinea Pedis Treatment Market: Vesicular Tinea Pedis Disease Type Segment to Reflect a High Growth Rate During the Forecast Period: Global Industry Analysis (2012 - 2016) and Opportunity Assessment (2017 - 2027)

Tinea Pedis Treatment Market: Vesicular Tinea Pedis Disease Type Segment to Reflect a High Growth Rate During the Forecast Period: Global Industry Analysis (2012 - 2016) and Opportunity Assessment (2017 - 2027)

Description of the research supporting your decision in investing in the report

The extensive research report titled “Tinea Pedis Treatment Market: Global Industry Analysis (2012-2016) and Opportunity Assessment (2017-2027)” crafted by Future Market Insights assists the reader in compiling and slating key growth strategies with a view to maintain correct growth rhythm in spite of the changing market dynamics in the current as well as in the future. Analysis on each segment of the market is included and assessment of these segments across key region in the globe is presented in a methodical format in the report.

The research reflects the global market view in a nutshell

The research report on tinea pedis treatment market covers various trends, opportunities, developments, drivers and restraints influencing the growth of the global market. These aspects are studied across key regional markets and their intensity is assessed from which the current and future market scenario is gauged. The statistics and data supporting these predictions are arranged in an orderly manner convenient for the reader to use. All the statistics are obtained keeping an unbiased view into consideration thus emphasizing on the authenticity of the research report. Moreover, deep diving in the segments along with a strong data mining process enables to sketch the possible future market direction and a complete scenario of the global tinea pedis treatment market with valuable acumen to offer need based solutions. The research on the global tinea pedis treatment market is carried out keeping a predefined purpose having clarity about the market, and involves appropriate statistical data based on a clear market definition.

The research follows a strong research methodology

Primary research and secondary research are used to glean relevant insights of the global tinea pedis treatment market. The research process includes several funnels of validation of the data to take the numbers to almost 100 percent accuracy. The data point associated with each segment is cross verified during every level of the primary research. Additionally, opinions from subject matter experts and market observers is also collated and with the help of triangulation method, data pertaining to respective market segments is obtained that radiates high precision.

The report covers weighted analysis of the competition scenario

The research report also includes a separate section focusing on the key players within the market. This section, called competitive analysis, uncovers all the major facts about the key companies involved in the activities pertaining to the global tinea pedis treatment market. Their product portfolio analysis, pricing strategies, marketing strategies, promotion tactics, expansion plans, regional spread, major developments and key innovations, mergers and acquisitions, important strategies, revenue, market shares, key personnel, other key financials etc., is included in this report that can give the reader a broad idea about the activities in the market based on which next moves can be planned. The companies included in this section are those which have enormous hold on the market and studying their tactics can definitely help the upcoming players to move up the ladder accomplishing their respective milestones.


1. Executive Summary
1.1. Overview
1.2. Market Analysis
1.3. FMI Analysis and Recommendations
1.4. Wheel of Fortune
2. Market Introduction
2.1. Market Taxonomy
2.2. Market Definition
3. Tinea Pedis Treatment Market View Point
3.1. Macro-Economic Factors
3.2. Opportunity Analysis
3.3. Incidence of Tinea Pedis
3.4. Regulatory Scenario
3.5. Pricing Analysis
4. North America Tinea Pedis Treatment Market Analysis 2012–2016 and Forecast 2017–2027
4.1. Introduction
4.2. Regional Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Trends
4.3. Historical Market Size (US$ Mn) Analysis By Country, 2012–2016
4.3.1. U.S.
4.3.2. Canada
4.4. Market Size (US$ Mn) Forecast By Country, 2017–2027
4.4.1. U.S.
4.4.2. Canada
4.5. Historical Market Size (US$ Mn) Analysis By Disease Type, 2012-2016
4.5.1. Interdigital Tinea Pedis
4.5.2. Plantar Tinea Pedis
4.5.3. Vesicular Tinea Pedis
4.6. Market Size (US$ Mn) Forecast By Disease Type, 2017-2027
4.6.1. Interdigital Tinea Pedis
4.6.2. Plantar Tinea Pedis
4.6.3. Vesicular Tinea Pedis
4.7. Historical Market Size (US$ Mn) Analysis By Drug Class, 2012-2016
4.7.1. Antifungals
4.7.2. Steroids and Anti-Infective Combinations
4.8. Market Size (US$ Mn) Forecast By Drug Class, 2017-2027
4.8.1. Antifungals
4.8.2. Steroids and Anti-Infective Combinations
4.9. Historical Market Size (US$ Mn) Analysis By Route of Administration, 2012-2016
4.9.1. Topical
4.9.1.1. Gel
4.9.1.2. Cream
4.9.1.3. Spray
4.9.1.4. Lotion
4.9.1.5. Powder
4.9.2. Oral
4.10. Market Size (US$ Mn) Forecast By Route of Administration, 2017-2027
4.10.1. Topical
4.10.1.1. Gel
4.10.1.2. Cream
4.10.1.3. Spray
4.10.1.4. Lotion
4.10.1.5. Powder
4.10.2. Oral
4.11. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2012-2016
4.11.1. Hospital Pharmacies
4.11.2. Retail Pharmacies
4.11.3. Drug Stores
4.11.4. Online Pharmacies
4.12. Market Size (US$ Mn) Forecast By Distribution Channel, 2017-2027
4.12.1. Hospital Pharmacies
4.12.2. Retail Pharmacies
4.12.3. Drug Stores
4.12.4. Online Pharmacies
4.13. Drivers and Restraints: Impact Analysis
4.14. Market Attractiveness Analysis
4.14.1. By Country
4.14.2. By Disease Type
4.14.3. By Drug Class
4.14.4. By Route of Administration
4.14.5. By Distribution Channel
5. Latin America Tinea Pedis Treatment Market Analysis 2012–2016 and Forecast 2017–2027
5.1. Introduction
5.2. Regional Market Dynamics
5.2.1. Drivers
5.2.2. Restraints
5.2.3. Trends
5.3. Historical Market Size (US$ Mn) Analysis By Country, 2012–2016
5.3.1. Brazil
5.3.2. Mexico
5.3.3. Rest of Latin America
5.4. Market Size (US$ Mn) Forecast By Country, 2017–2027
5.4.1. Brazil
5.4.2. Mexico
5.4.3. Rest of Latin America
5.5. Historical Market Size (US$ Mn) Analysis By Disease Type, 2012-2016
5.5.1. Interdigital Tinea Pedis
5.5.2. Plantar Tinea Pedis
5.5.3. Vesicular Tinea Pedis
5.6. Market Size (US$ Mn) Forecast By Disease Type, 2017-2027
5.6.1. Interdigital Tinea Pedis
5.6.2. Plantar Tinea Pedis
5.6.3. Vesicular Tinea Pedis
5.7. Historical Market Size (US$ Mn) Analysis By Drug Class, 2012-2016
5.7.1. Antifungals
5.7.2. Steroids and Anti-Infective Combinations
5.8. Market Size (US$ Mn) Forecast By Drug Class, 2017-2027
5.8.1. Antifungals
5.8.2. Steroids and Anti-Infective Combinations
5.9. Historical Market Size (US$ Mn) Analysis By Route of Administration, 2012-2016
5.9.1. Topical
5.9.1.1. Gel
5.9.1.2. Cream
5.9.1.3. Spray
5.9.1.4. Lotion
5.9.1.5. Powder
5.9.2. Oral
5.10. Market Size (US$ Mn) Forecast By Route of Administration, 2017-2027
5.10.1. Topical
5.10.1.1. Gel
5.10.1.2. Cream
5.10.1.3. Spray
5.10.1.4. Lotion
5.10.1.5. Powder
5.10.2. Oral
5.11. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2012-2016
5.11.1. Hospital Pharmacies
5.11.2. Retail Pharmacies
5.11.3. Drug Stores
5.11.4. Online Pharmacies
5.12. Market Size (US$ Mn) Forecast By Distribution Channel, 2017-2027
5.12.1. Hospital Pharmacies
5.12.2. Retail Pharmacies
5.12.3. Drug Stores
5.12.4. Online Pharmacies
5.13. Drivers and Restraints: Impact Analysis
5.14. Market Attractiveness Analysis
5.14.1. By Country
5.14.2. By Disease Type
5.14.3. By Drug Class
5.14.4. By Route of Administration
5.14.5. By Distribution Channel
6. Western Europe Tinea Pedis Treatment Market Analysis 2012–2016 and Forecast 2017–2027
6.1. Introduction
6.2. Regional Market Dynamics
6.2.1. Drivers
6.2.2. Restraints
6.2.3. Trends
6.3. Historical Market Size (US$ Mn) Analysis By Country, 2012–2016
6.3.1. Germany
6.3.2. Italy
6.3.3. France
6.3.4. Spain
6.3.5. U.K.
6.3.6. BENELUX
6.3.7. Nordic
6.3.8. Rest of Western Europe
6.4. Market Size (US$ Mn) Forecast By Country, 2017–2027
6.4.1. Germany
6.4.2. Italy
6.4.3. France
6.4.4. Spain
6.4.5. U.K.
6.4.6. BENELUX
6.4.7. Nordic
6.4.8. Rest of Western Europe
6.5. Historical Market Size (US$ Mn) Analysis By Disease Type, 2012-2016
6.5.1. Interdigital Tinea Pedis
6.5.2. Plantar Tinea Pedis
6.5.3. Vesicular Tinea Pedis
6.6. Market Size (US$ Mn) Forecast By Disease Type, 2017-2027
6.6.1. Interdigital Tinea Pedis
6.6.2. Plantar Tinea Pedis
6.6.3. Vesicular Tinea Pedis
6.7. Historical Market Size (US$ Mn) Analysis By Drug Class, 2012-2016
6.7.1. Antifungals
6.7.2. Steroids and Anti-Infective Combinations
6.8. Market Size (US$ Mn) Forecast By Drug Class, 2017-2027
6.8.1. Antifungals
6.8.2. Steroids and Anti-Infective Combinations
6.9. Historical Market Size (US$ Mn) Analysis By Route of Administration, 2012-2016
6.9.1. Topical
6.9.1.1. Gel
6.9.1.2. Cream
6.9.1.3. Spray
6.9.1.4. Lotion
6.9.1.5. Powder
6.9.2. Oral
6.10. Market Size (US$ Mn) Forecast By Route of Administration, 2017-2027
6.10.1. Topical
6.10.1.1. Gel
6.10.1.2. Cream
6.10.1.3. Spray
6.10.1.4. Lotion
6.10.1.5. Powder
6.10.2. Oral
6.11. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2012-2016
6.11.1. Hospital Pharmacies
6.11.2. Retail Pharmacies
6.11.3. Drug Stores
6.11.4. Online Pharmacies
6.12. Market Size (US$ Mn) Forecast By Distribution Channel, 2017-2027
6.12.1. Hospital Pharmacies
6.12.2. Retail Pharmacies
6.12.3. Drug Stores
6.12.4. Online Pharmacies
6.13. Drivers and Restraints: Impact Analysis
6.14. Market Attractiveness Analysis
6.14.1. By Country
6.14.2. By Disease Type
6.14.3. By Drug Class
6.14.4. By Route of Administration
6.14.5. By Distribution Channel
7. Eastern Europe Tinea Pedis Treatment Market Analysis 2012–2016 and Forecast 2017–2027
7.1. Introduction
7.2. Regional Market Dynamics
7.2.1. Drivers
7.2.2. Restraints
7.2.3. Trends
7.3. Historical Market Size (US$ Mn) Analysis By Country, 2012–2016
7.3.1. Russia
7.3.2. Poland
7.3.3. Rest of Eastern Europe
7.4. Market Size (US$ Mn) Forecast By Country, 2017–2027
7.4.1. Russia
7.4.2. Poland
7.4.3. Rest of Eastern Europe
7.5. Historical Market Size (US$ Mn) Analysis By Disease Type, 2012-2016
7.5.1. Interdigital Tinea Pedis
7.5.2. Plantar Tinea Pedis
7.5.3. Vesicular Tinea Pedis
7.6. Market Size (US$ Mn) Forecast By Disease Type, 2017-2027
7.6.1. Interdigital Tinea Pedis
7.6.2. Plantar Tinea Pedis
7.6.3. Vesicular Tinea Pedis
7.7. Historical Market Size (US$ Mn) Analysis By Drug Class, 2012-2016
7.7.1. Antifungals
7.7.2. Steroids and Anti-Infective Combinations
7.8. Market Size (US$ Mn) Forecast By Drug Class, 2017-2027
7.8.1. Antifungals
7.8.2. Steroids and Anti-Infective Combinations
7.9. Historical Market Size (US$ Mn) Analysis By Route of Administration, 2012-2016
7.9.1. Topical
7.9.1.1. Gel
7.9.1.2. Cream
7.9.1.3. Spray
7.9.1.4. Lotion
7.9.1.5. Powder
7.9.2. Oral
7.10. Market Size (US$ Mn) Forecast By Route of Administration, 2017-2027
7.10.1. Topical
7.10.1.1. Gel
7.10.1.2. Cream
7.10.1.3. Spray
7.10.1.4. Lotion
7.10.1.5. Powder
7.10.2. Oral
7.11. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2012-2016
7.11.1. Hospital Pharmacies
7.11.2. Retail Pharmacies
7.11.3. Drug Stores
7.11.4. Online Pharmacies
7.12. Market Size (US$ Mn) Forecast By Distribution Channel, 2017-2027
7.12.1. Hospital Pharmacies
7.12.2. Retail Pharmacies
7.12.3. Drug Stores
7.12.4. Online Pharmacies
7.13. Drivers and Restraints: Impact Analysis
7.14. Market Attractiveness Analysis
7.14.1. By Country
7.14.2. By Disease Type
7.14.3. By Drug Class
7.14.4. By Route of Administration
7.14.5. By Distribution Channel
8. Asia Pacific excluding Japan Tinea Pedis Treatment Market Analysis 2012–2016 and Forecast 2017–2027
8.1. Introduction
8.2. Regional Market Dynamics
8.2.1. Drivers
8.2.2. Restraints
8.2.3. Trends
8.3. Historical Market Size (US$ Mn) Analysis By Country, 2012–2016
8.3.1. China
8.3.2. India
8.3.3. Australia and New Zealand
8.3.4. ASEAN
8.3.5. Rest of APEJ
8.4. Market Size (US$ Mn) Forecast By Country, 2017–2027
8.4.1. China
8.4.2. India
8.4.3. Australia and New Zealand
8.4.4. ASEAN
8.4.5. Rest of APEJ
8.5. Historical Market Size (US$ Mn) Analysis By Disease Type, 2012-2016
8.5.1. Interdigital Tinea Pedis
8.5.2. Plantar Tinea Pedis
8.5.3. Vesicular Tinea Pedis
8.6. Market Size (US$ Mn) Forecast By Disease Type, 2017-2027
8.6.1. Interdigital Tinea Pedis
8.6.2. Plantar Tinea Pedis
8.6.3. Vesicular Tinea Pedis
8.7. Historical Market Size (US$ Mn) Analysis By Drug Class, 2012-2016
8.7.1. Antifungals
8.7.2. Steroids and Anti-Infective Combinations
8.8. Market Size (US$ Mn) Forecast By Drug Class, 2017-2027
8.8.1. Antifungals
8.8.2. Steroids and Anti-Infective Combinations
8.9. Historical Market Size (US$ Mn) Analysis By Route of Administration, 2012-2016
8.9.1. Topical
8.9.1.1. Gel
8.9.1.2. Cream
8.9.1.3. Spray
8.9.1.4. Lotion
8.9.1.5. Powder
8.9.2. Oral
8.10. Market Size (US$ Mn) Forecast By Route of Administration, 2017-2027
8.10.1. Topical
8.10.1.1. Gel
8.10.1.2. Cream
8.10.1.3. Spray
8.10.1.4. Lotion
8.10.1.5. Powder
8.10.2. Oral
8.11. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2012-2016
8.11.1. Hospital Pharmacies
8.11.2. Retail Pharmacies
8.11.3. Drug Stores
8.11.4. Online Pharmacies
8.12. Market Size (US$ Mn) Forecast By Distribution Channel, 2017-2027
8.12.1. Hospital Pharmacies
8.12.2. Retail Pharmacies
8.12.3. Drug Stores
8.12.4. Online Pharmacies
8.13. Drivers and Restraints: Impact Analysis
8.14. Market Attractiveness Analysis
8.14.1. By Country
8.14.2. By Disease Type
8.14.3. By Drug Class
8.14.4. By Route of Administration
8.14.5. By Distribution Channel
9. Japan Tinea Pedis Treatment Market Analysis 2012–2016 and Forecast 2017–2027
9.1. Introduction
9.2. Regional Market Dynamics
9.2.1. Drivers
9.2.2. Restraints
9.2.3. Trends
9.3. Historical Market Size (US$ Mn) Analysis By Disease Type, 2012-2016
9.3.1. Interdigital Tinea Pedis
9.3.2. Plantar Tinea Pedis
9.3.3. Vesicular Tinea Pedis
9.4. Market Size (US$ Mn) Forecast By Disease Type, 2017-2027
9.4.1. Interdigital Tinea Pedis
9.4.2. Plantar Tinea Pedis
9.4.3. Vesicular Tinea Pedis
9.5. Historical Market Size (US$ Mn) Analysis By Drug Class, 2012-2016
9.5.1. Antifungals
9.5.2. Steroids and Anti-Infective Combinations
9.6. Market Size (US$ Mn) Forecast By Drug Class, 2017-2027
9.6.1. Antifungals
9.6.2. Steroids and Anti-Infective Combinations
9.7. Historical Market Size (US$ Mn) Analysis By Route of Administration, 2012-2016
9.7.1. Topical
9.7.1.1. Gel
9.7.1.2. Cream
9.7.1.3. Spray
9.7.1.4. Lotion
9.7.1.5. Powder
9.7.2. Oral
9.8. Market Size (US$ Mn) Forecast By Route of Administration, 2017-2027
9.8.1. Topical
9.8.1.1. Gel
9.8.1.2. Cream
9.8.1.3. Spray
9.8.1.4. Lotion
9.8.1.5. Powder
9.8.2. Oral
9.9. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2012-2016
9.9.1. Hospital Pharmacies
9.9.2. Retail Pharmacies
9.9.3. Drug Stores
9.9.4. Online Pharmacies
9.10. Market Size (US$ Mn) Forecast By Distribution Channel, 2017-2027
9.10.1. Hospital Pharmacies
9.10.2. Retail Pharmacies
9.10.3. Drug Stores
9.10.4. Online Pharmacies
9.11. Drivers and Restraints: Impact Analysis
9.12. Market Attractiveness Analysis
9.12.1. By Disease Type
9.12.2. By Drug Class
9.12.3. By Route of Administration
9.12.4. By Distribution Channel
10. Middle East & Africa Tinea Pedis Treatment Market Analysis 2012–2016 and Forecast 2017–2027
10.1. Introduction
10.2. Regional Market Dynamics
10.2.1. Drivers
10.2.2. Restraints
10.2.3. Trends
10.3. Historical Market Size (US$ Mn) Analysis By Country, 2012–2016
10.3.1. GCC Countries
10.3.2. South Africa
10.3.3. Rest of MEA
10.4. Market Size (US$ Mn) Forecast By Country, 2017–2027
10.4.1. GCC Countries
10.4.2. South Africa
10.4.3. Rest of MEA
10.5. Historical Market Size (US$ Mn) Analysis By Disease Type, 2012-2016
10.5.1. Interdigital Tinea Pedis
10.5.2. Plantar Tinea Pedis
10.5.3. Vesicular Tinea Pedis
10.6. Market Size (US$ Mn) Forecast By Disease Type, 2017-2027
10.6.1. Interdigital Tinea Pedis
10.6.2. Plantar Tinea Pedis
10.6.3. Vesicular Tinea Pedis
10.7. Historical Market Size (US$ Mn) Analysis By Drug Class, 2012-2016
10.7.1. Antifungals
10.7.2. Steroids and Anti-Infective Combinations
10.8. Market Size (US$ Mn) Forecast By Drug Class, 2017-2027
10.8.1. Antifungals
10.8.2. Steroids and Anti-Infective Combinations
10.9. Historical Market Size (US$ Mn) Analysis By Route of Administration, 2012-2016
10.9.1. Topical
10.9.1.1. Gel
10.9.1.2. Cream
10.9.1.3. Spray
10.9.1.4. Lotion
10.9.1.5. Powder
10.9.2. Oral
10.10. Market Size (US$ Mn) Forecast By Route of Administration, 2017-2027
10.10.1. Topical
10.10.1.1. Gel
10.10.1.2. Cream
10.10.1.3. Spray
10.10.1.4. Lotion
10.10.1.5. Powder
10.10.2. Oral
10.11. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2012-2016
10.11.1. Hospital Pharmacies
10.11.2. Retail Pharmacies
10.11.3. Drug Stores
10.11.4. Online Pharmacies
10.12. Market Size (US$ Mn) Forecast By Distribution Channel, 2017-2027
10.12.1. Hospital Pharmacies
10.12.2. Retail Pharmacies
10.12.3. Drug Stores
10.12.4. Online Pharmacies
10.13. Drivers and Restraints: Impact Analysis
10.14. Market Attractiveness Analysis
10.14.1. By Country
10.14.2. By Disease Type
10.14.3. By Drug Class
10.14.4. By Route of Administration
10.14.5. By Distribution Channel
11. Forecast Factors: Relevance and Impact
12. Forecast Assumptions
13. Competition Landscape
13.1. Competition Dashboard
13.2. Company Profiles (Details – Overview, Financials, Strategy, SWOT, Recent Developments)
13.2.1. Perrigo Company
13.2.2. Taro Pharmaceuticals U.S.A., Inc.
13.2.3. Teva Pharmaceuticals, Inc.
13.2.4. Glenmark Pharmaceuticals Inc., USA
13.2.5. Breckenridge Pharmaceutical, Inc.
13.2.6. NorthStar Rx LLC
13.2.7. Aurobindo Pharma Limited
13.2.8. Camber Pharmaceuticals, Inc.
13.2.9. AvKare, Inc.
13.2.10. Novartis AG
13.2.11. Sebela Pharmaceuticals, Inc.
13.2.12. Bayer AG
13.2.13. Blueberry Therapeutics Ltd.
13.2.14. GlaxoSmithKline plc.
13.2.15. Exeltis USA
13.2.16. Valeant Pharmaceuticals, Inc.
13.2.17. CorePharma, LLC
13.2.18. McNeil Consumer Healthcare
13.2.19. Aqua Pharmaceuticals LLC
13.2.20. Mylan N.V.
14. Global Tinea Pedis Treatment Market Analysis 2012–2016 and Forecast 2017–2027, By Region
14.1. Introduction/Key Findings
14.2. Historical Market Size (US$ Mn) Trend Analysis By Region, 2012–2016
14.2.1. North America
14.2.2. Latin America
14.2.3. Western Europe
14.2.4. Eastern Europe
14.2.5. Asia Pacific excluding Japan
14.2.6. Japan
14.2.7. Middle East & Africa
14.3. Market Size (US$ Mn) Forecast By Region, 2017–2027
14.3.1. North America
14.3.2. Latin America
14.3.3. Western Europe
14.3.4. Eastern Europe
14.3.5. Asia Pacific excluding Japan
14.3.6. Japan
14.3.7. Middle East & Africa
14.4. Market Attractiveness Analysis By Region
15. Global Tinea Pedis Treatment Market Analysis 2012–2016 and Forecast 2017–2027, By Disease Type
15.1. Introduction/Key Findings
15.2. Historical Market Size (US$ Mn) Trend Analysis By Disease Type, 2012–2016
15.2.1. Interdigital Tinea Pedis
15.2.2. Plantar Tinea Pedis
15.2.3. Vesicular Tinea Pedis
15.3. Market Size (US$ Mn) Forecast By Disease Type, 2017–2027
15.3.1. Interdigital Tinea Pedis
15.3.2. Plantar Tinea Pedis
15.3.3. Vesicular Tinea Pedis
15.4. Market Attractiveness Analysis By Disease Type
16. Global Tinea Pedis Treatment Market Analysis 2012–2016 and Forecast 2017–2027, By Drug Class
16.1. Introduction/Key Findings
16.2. Historical Market Size (US$ Mn) Trend Analysis By Drug Class, 2012–2016
16.2.1. Antifungals
16.2.2. Steroids and Anti-Infective Combinations
16.3. Market Size (US$ Mn) Forecast By Drug Class, 2017–2027
16.3.1. Antifungals
16.3.2. Steroids and Anti-Infective Combinations
16.4. Market Attractiveness Analysis By Drug Class
17. Global Tinea Pedis Treatment Market Analysis 2012–2016 and Forecast 2017–2027, By Route of Administration
17.1. Introduction/Key Findings
17.2. Historical Market Size (US$ Mn) Trend Analysis By Route of Administration, 2012–2016
17.2.1. Topical
17.2.1.1. Gel
17.2.1.2. Cream
17.2.1.3. Spray
17.2.1.4. Lotion
17.2.1.5. Powder
17.2.2. Oral
17.3. Market Size (US$ Mn) Forecast By Route of Administration, 2017–2027
17.3.1. Topical
17.3.1.1. Gel
17.3.1.2. Cream
17.3.1.3. Spray
17.3.1.4. Lotion
17.3.1.5. Powder
17.3.2. Oral
17.4. Market Attractiveness Analysis By Route of Administration
18. Global Tinea Pedis Treatment Market Analysis 2012–2016 and Forecast 2017–2027, By Distribution Channel
18.1. Introduction/Key Findings
18.2. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2012–2016
18.2.1. Hospital Pharmacies
18.2.2. Retail Pharmacies
18.2.3. Drug Stores
18.2.4. Online Pharmacies
18.3. Market Size (US$ Mn) Forecast By Distribution Channel, 2017–2027
18.3.1. Hospital Pharmacies
18.3.2. Retail Pharmacies
18.3.3. Drug Stores
18.3.4. Online Pharmacies
18.4. Market Attractiveness Analysis By Distribution Channel
19. Global Tinea Pedis Treatment Market Analysis 2012–2016 and Forecast 2017–2027
19.1. Market Size and Y-o-Y Growth
19.2. Absolute $ Opportunity
19.3 Market Value Chain
List of Tables
Table 01: AntiFungals and their usual concentrations
Table 2: North America Tinea Pedis Treatments Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Country
Table 3: North America Tinea Pedis Treatments Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Disease Type
Table 4: North America Tinea Pedis Treatments Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Drug Class
Table 5: North America Tinea Pedis Treatments Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Route of Administration
Table 6: North America Tinea Pedis Treatments Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Distribution Channel
Table 7: Latin America Tinea Pedis Treatments Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Country
Table 8: Latin America Tinea Pedis Treatments Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Disease Type
Table 9: Latin America Tinea Pedis Treatments Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Drug Class
Table 10: Latin America Tinea Pedis Treatments Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Route of Administration
Table 11: Latin America Tinea Pedis Treatments Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Distribution Channel
Table 12: Western Europe Tinea Pedis Treatments Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Country
Table 13: Western Europe Tinea Pedis Treatments Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Disease Type
Table 14: Western Europe Tinea Pedis Treatments Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Drug Class
Table 15: Western Europe Tinea Pedis Treatments Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Route of Administration
Table 16: Western Europe Tinea Pedis Treatments Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Distribution Channel
Table 17: Eastern Europe Tinea Pedis Treatments Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Country
Table 18: Eastern Europe Tinea Pedis Treatments Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Disease Type
Table 19: Eastern Europe Tinea Pedis Treatments Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Drug Class
Table 20: Eastern Europe Tinea Pedis Treatments Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Route of Administration
Table 21: Eastern Europe Tinea Pedis Treatments Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Distribution Channel
Table 22: APEJ Tinea Pedis Treatments Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Country
Table 23: APEJ Tinea Pedis Treatments Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Disease Type
Table 24: APEJ Tinea Pedis Treatments Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Drug Class
Table 25: APEJ Tinea Pedis Treatments Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Route of Administration
Table 26: APEJ Tinea Pedis Treatments Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Distribution Channel
Table 27: Japan Tinea Pedis Treatments Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Disease Type
Table 28: Japan Tinea Pedis Treatments Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Drug Class
Table 29: Japan Tinea Pedis Treatments Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Route of Administration
Table 30: Japan Tinea Pedis Treatments Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Distribution Channel
Table 31: MEA Tinea Pedis Treatments Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Country
Table 32: MEA Tinea Pedis Treatments Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Disease Type
Table 33: MEA Tinea Pedis Treatments Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Drug Class
Table 34: MEA Tinea Pedis Treatments Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Route of Administration
Table 35: MEA Tinea Pedis Treatments Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Distribution Channel
Table 36: North America Tinea Pedis Treatments Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Region
Table 37: Global Tinea Pedis Treatments Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Disease Type
Table 38: Global Tinea Pedis Treatments Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Drug Class
Table 39: Global Tinea Pedis Treatments Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Route of Administration
Table 40: Global Tinea Pedis Treatments Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Distribution Channel

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report